Molgramostim biosimilar - Reliance GeneMedixAlternative Names: GM-CSF - Reliance GeneMedix; Neustim
Latest Information Update: 16 Jun 2015
At a glance
- Originator GeneMedix Plc
- Developer Reliance GeneMedix
- Class Chemoprotectants; Granulocyte-macrophage colony-stimulating factors; Recombinant proteins
- Mechanism of Action Granulocyte macrophage colony stimulating factor agonists; Immunomodulators
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Marketed Neutropenia